IDH1 and glioma: By combining tumor organoids of various glioma subtypes with in vivo expansion in the brain microenvironment, we present a cohort of 40 PDOX generated from primary and paired recurrent gliomas with mixed genetic backgrounds including, among others, IDH1 mutation and distinct EGFR variants.